New drug trial targets rare blood disorder where body attacks its own red cells
Disease control
Ongoing
This clinical trial is testing an investigational drug called HMPL-523 for adults with warm antibody autoimmune hemolytic anemia (wAIHA), a condition where the immune system mistakenly destroys red blood cells. The study aims to see if the drug can safely and effectively increase…
Phase: PHASE2, PHASE3 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC